Document is current
Any future updates will be listed below
-
Authors
Miao, Xinwen
Law, Michelle Cheok Yien
Kumar, Jatin
Chng, Choon-Peng
Zeng, Yongpeng
Tan, Yaw Bia
Wu, Jiawei
Guo, Xiangfu
Huang, Lizhen
Zhuang, Yinyin https://orcid.org/0000-0002-3893-471X
Gao, Weibo https://orcid.org/0000-0003-3971-621X
Huang, Changjin https://orcid.org/0000-0002-1941-1200
Luo, Dahai https://orcid.org/0000-0001-7637-7275
Zhao, Wenting https://orcid.org/0000-0002-6143-5185
-
Funding
Funding for this research was provided by:
National Research Foundation Singapore (NRF-MSG-2023-0001, NRF2021-QEP2-03-P10)
Human Frontier Science Program (RGY0088/2021)
Ministry of Education - Singapore (EDUN C-33-18-279-V12, MOET32020-0001; MOET32023-0004, MOET2EP30222-0022, MOE-T2EP50121-0004, RG84/21; RT22/23, MOE-T2EP30220-0009; MOE-T2EP30124-0023)
Nanyang Technological University Start-Up Grant
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 22 April 2025
First Online: 8 May 2025
Competing interests
: The following authors declare competing interests: W.Z., D.L., and X.M. are listed as inventors on a patent application (10202500872Q) filed by Nanyang Technological University, related to an anti-viral drug screening platform. The remaining authors declare no competing interests.
